A nurse is caring for a client who has been taking oxymetazoline (Afrin) nasal spray for the past 10 days for allergic rhinitis. The nurse should monitor the client for which of the following manifestations as an adverse effect of this medication?

A) Sedation:
Sedation is not an adverse effect commonly associated with oxymetazoline nasal spray. Oxymetazoline works by constricting blood vessels in the nasal passages to relieve congestion and does not typically cause sedation.

B) Constipation:
Constipation is not an adverse effect associated with oxymetazoline nasal spray. Constipation is more commonly associated with medications that affect the gastrointestinal system, such as opioid analgesics or certain anticholinergic medications.

C) Productive cough:
Productive cough is not an adverse effect commonly associated with oxymetazoline nasal spray. Productive cough refers to a cough that produces mucus or phlegm and is more often associated with respiratory infections or chronic respiratory conditions.

D) Nasal congestion.
Oxymetazoline (Afrin) is a nasal decongestant spray commonly used for the temporary relief of nasal congestion associated with allergic rhinitis or the common cold. However, if oxymetazoline nasal spray is used for more than 3 to 5 consecutive days, it can lead to rebound congestion, also known as rhinitis medicamentosa. Rebound congestion occurs when the nasal mucosa becomes dependent on the medication for vasoconstriction, and upon discontinuation, nasal congestion worsens. Therefore, prolonged use of oxymetazoline nasal spray can result in a worsening of nasal congestion as an adverse effect.

A) "I will take the medication for diarrhea."
Docusate sodium is not typically used to treat diarrhea. It is specifically indicated for constipation and is not effective for treating diarrhea.

B) "I will have soft stools 1 to 3 days after starting this medication."
Docusate sodium is a stool softener used to treat constipation by increasing the amount of water absorbed by the stool in the intestines, making it softer and easier to pass. The client's understanding that soft stools should occur 1 to 3 days after starting the medication demonstrates comprehension of the medication's expected effect.

C) "I will drink one half glass of water when I take the medication."
While it's generally a good idea to take docusate sodium with a full glass of water to help prevent dehydration and facilitate the softening of stool, the statement doesn't address the intended effect of the medication or the timing of stool softening.

D) "I can take this medication with mineral oil."
Taking docusate sodium with mineral oil is not recommended without consulting a healthcare provider. Mineral oil can interfere with the absorption of docusate sodium and reduce its effectiveness. It's important for the client to follow their healthcare provider's instructions regarding medication administration.